🔗 Share this article

Chancellor Rachel Reeves has stated she is preparing "specific action to tackle cost of living pressures" in the upcoming financial statement.

Speaking to the BBC, she emphasized that lowering inflation is a joint duty of both the administration and the central bank.

The UK's inflation rate is expected to be the most elevated among the G7 developed nations this year and next.

Potential Energy Cost Measures

It is understood the administration could take action to reduce utility costs, for instance by slashing the current 5% level of VAT applied on energy.

Another possibility is to reduce some of the government charges currently added to household expenses.

Budgetary Limitations and Analyst Expectations

The government will receive the latest assessment from the official forecaster, the Office for Budget Responsibility, on Monday, which will clarify how much scope there is for such measures.

The view from most economists is that Reeves will have to introduce tax rises or budget cuts in order to adhere to her declared fiscal targets.

Earlier on Thursday, analysis showed there was a twenty-two billion pound gap for the chancellor to address, which is at the lower end of expectations.

"It is a collective job between the Bank of England and the administration to bear down further on some of the causes of inflation," Reeves told the BBC in the US capital, at the conferences of the International Monetary Fund and global financial institution.

Revenue Commitments and Global Concerns

While a great deal of the attention has been on likely tax increases, the chancellor said the most recent information from the OBR had not altered her pledge to election pledges not to increase tax levels on income tax, sales tax or social security contributions.

She blamed an "uncertain global environment" with increasing international and trade issues for the Budget revenue measures, likely to be directed on those "most able to pay."

International Trade Disputes

Referring to apprehensions about the United Kingdom's commercial links with China she said: "The UK's security interests always come first."

Last week's declaration by China to tighten trade restrictions on critical minerals and other resources that are crucial for high-technology manufacturing led US President the US President to threaten an further 100% tariff on goods from the Asian country, raising the possibility of an all-out commercial conflict between the two largest economies.

The US Treasury Secretary labeled the Chinese move "economic coercion" and "a global supply chain power grab."

Asked about considering the US offer to join its dispute with the Asian nation, Reeves said she was "extremely troubled" by China's measures and called on the Chinese government "not to put up barriers and restrict access."

She said the move was "damaging for the world economy and creates further challenges."

"In my view there are fields where we need to address Chinese policies, but there are also valuable opportunities to trade with China's economy, including financial services and other sectors of the economic system. We've got to get that balance right."

The chancellor also stated she was cooperating with international partners "regarding our own essential resources strategy, so that we are more independent."

Health Service Drug Costs and Funding

The Chancellor also recognized that the price the NHS spends on drugs could go up as a consequence of ongoing discussions with the US government and its drugs companies, in return for lower tariffs and capital.

A number of the world's largest pharmaceutical manufacturers have said in recent statements that they are either delaying or scrapping operations in the United Kingdom, with some blaming the modest returns they are receiving.

Last month, the government science advisor said the price the NHS pays for drugs would need to increase to prevent businesses and drug research funding leaving the United Kingdom.

The Chancellor told media: "It has been observed due to the pricing regime, that drug testing, recent pharmaceuticals have not been available in the UK in the way that they are in other continental states."

"The objective is to ensure that patients getting treatment from the NHS are able to obtain the best critical drugs in the globe. And so we are looking at all of that, and... seeking to attract additional capital into the UK."